Novel AChE and BChE inhibitors using combined virtual screening, text mining and in vitro binding assays

References

• Anand, R., Gill, K. D., & Mahdi, A. A. (2014). Therapeutics of Alzheimer's disease: Past, present and future. Neuropharmacology, 76(Pt A), 27–50. doi:10.1016/j.neuropharm.2013.07.004
   PubMed Web of Science ®Google Scholar
• Auld, D. S., Kornecook, T. J., Bastianetto, S., & Quirion, R. (2002). Alzheimer’s disease and the basal forebrain cholinergic system: Relations to beta-amyloid peptides, cognition, and treatment strategies. Progress in Neurobiology, 68(3), 209–245. doi:10.1016/S0301-0082(02)00079-5
   PubMed Web of Science ®Google Scholar
• Bandini, M. (2013). Electrophilicity: the “dark-side” of indole chemistry. Organic & Biomolecular Chemistry, 11(32), 5206–5212. doi:10.1039/c3ob40735g
   PubMed Web of Science ®Google Scholar
• Banks, J. L., Beard, H. S., Cao, Y., Cho, A. E., Damm, W., Farid, R., … Levy, R. M. (2005). Integrated Modeling Program, Applied Chemical Theory (IMPACT). Journal of Computational Chemistry, 26(16), 1752–1780. doi:10.1002/jcc.20292
   PubMed Web of Science ®Google Scholar
• Bashford, D., & Case, D. A. (2000). Generalized born models of macromolecular solvation effects. Annual Review of Physical Chemistry, 51(1), 129–152. doi:10.1146/annurev.physchem.51.1.129
   PubMedGoogle Scholar
• Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., & Hermans, J. (1981). Interaction models for water in relation to protein hydration (pp. 331–342). Dordrecht: Springer Netherlands.
   Google Scholar
• Beveridge, D. L., & DiCapua, F. M. (1989). Free energy via molecular simulation: Applications to chemical and biomolecular systems. Annual Review of Biophysics and Biophysical Chemistry, 18(1), 431–492. doi:10.1146/annurev.bb.18.060189.002243
   PubMedGoogle Scholar
• Binkowski, T. A., Jiang, W., Roux, B., Anderson, W. F., & Joachimiak, A. (2014). Virtual high-throughput ligand screening. Methods in Molecular Biology, 1140, 251–261. doi:10.1007/978-1-4939-0354-2_19
   PubMedGoogle Scholar
• Birks, J. (2006). Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Database of Systematic Reviews, 1, CD005593.
   PubMed Web of Science ®Google Scholar
• Camacho, C. J., & Vajda, S. (2002). Protein–protein association kinetics and protein docking. Current Opinion in Structural Biology, 12(1), 36–40. doi:10.1016/S0959-440X(02)00286-5
   PubMed Web of Science ®Google Scholar
• Cheung, J., Rudolph, M. J., Burshteyn, F., Cassidy, M. S., Gary, E. N., Love, J., … Height, J. J. (2012). Structures of human acetylcholinesterase in complex with pharmacologically important ligands. Journal of Medicinal Chemistry, 55(22), 10282–10286. doi:10.1021/jm300871x
   PubMed Web of Science ®Google Scholar
• Chhabra, S., Sharma, P., & Ghoshal, N. (2007). A computational docking study for prediction of binding mode of diospyrin and derivatives: Inhibitors of human and leishmanial DNA topoisomerase-I. Bioorganic & Medicinal Chemistry Letters, 17(16), 4604–4612.
   PubMedGoogle Scholar
• Desmond molecular dynamics program. (2017). New York.
   Google Scholar
• Durdagi, S., Salmas, R. E., Stein, M., Yurtsever, M., & Seeman, P. (2016). Binding interactions of dopamine and apomorphine in D2High and D2Low states of human dopamine D2 receptor using computational and experimental techniques. ACS Chemical Neuroscience, 7(2), 185–195. doi:10.1021/acschemneuro.5b00271
   PubMed Web of Science ®Google Scholar
• Ellman, G. L., Courtney, K. D., Andres, V., & Feather-Stone, R. M. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology, 7(2), 88–95. doi:10.1016/0006-2952(61)90145-9
   PubMed Web of Science ®Google Scholar
• Farlow, M. R., Miller, M. L., & Pejovic, V. (2008). Treatment options in Alzheimer’s disease: Maximizing benefit, managing expectations. Dementia and Geriatric Cognitive Disorders, 25(5), 408–422. doi:10.1159/000122962
   PubMed Web of Science ®Google Scholar
• Giacobini, E. (2004). Cholinesterase inhibitors: New roles and therapeutic alternatives. Pharmacological Research, 50(4), 433–440. doi:10.1016/j.phrs.2003.11.017
   PubMed Web of Science ®Google Scholar
• Glide, Version 5.7. (2011). New York: Schrodinger, LLC.
   Google Scholar
• Gschwend, D. A., Good, A. C., & Kuntz, I. D. (1996). Molecular docking towards drug discovery. Journal of Molecular Recognition, 9(2), 175–186. doi:10.1002/(SICI)1099-1352(199603)9:2%3C175::AID-JMR260%3E3.0.CO;2-D
   PubMed Web of Science ®Google Scholar
• Hoover, W. G. (1985). Canonical dynamics: Equilibrium phase-space distributions. Physical Review A, 31(3), 1695–1697. doi:10.1103/PhysRevA.31.1695
   PubMed Web of Science ®Google Scholar
• Hopkins, F. G., & Cole, S. W. (1901). A contribution to the chemistry of proteids: Part I. A preliminary study of a hitherto undescribed product of tryptic digestion. The Journal of Physiology, 27(4–5), 418–428. doi:10.1113/jphysiol.1901.sp000880
   PubMedGoogle Scholar
• Hou, T., Wang, J., Li, Y., & Wang, W. (2011a). Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. Journal of Chemical Information and Modeling, 51(1), 69–82. doi:10.1021/ci100275a
   PubMed Web of Science ®Google Scholar
• Hou, T., Wang, J., Li, Y., & Wang, W. (2011b). Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from docking. Journal of Computational Chemistry, 32(5), 866–877. doi:10.1002/jcc.21666
   PubMed Web of Science ®Google Scholar
• Jacobson, M. P., Pincus, D. L., Rapp, C. S., Day, T. J., Honig, B., Shaw, D. E., & Friesner, R. A. (2004). A hierarchical approach to all-atom protein loop prediction. Proteins: Structure, Function and Bioinformatics, 55(2), 351–367. doi:10.1002/prot.10613
   PubMed Web of Science ®Google Scholar
• Jones, G., Willett, P., Glen, R. C., Leach, A. R., & Taylor, R. (1997). Development and validation of a genetic algorithm for flexible docking. Journal of Molecular Biology, 267(3), 727–748. doi:10.1006/jmbi.1996.0897
   PubMed Web of Science ®Google Scholar
• Kollman, P. A., Massova, I., Reyes, C., Kuhn, B., Huo, S., Chong, L., … Cheatham, T. E. (2000). Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models. Accounts of Chemical Research, 33(12), 889–897. doi:10.1021/ar000033j
   PubMed Web of Science ®Google Scholar
• Krallinger, M., & Valencia, A. (2005). Text-mining and information-retrieval services for molecular biology. Genome Biology, 6(7), 224. doi:10.1186/gb-2005-6-7-224
   PubMed Web of Science ®Google Scholar
• Lane, R. M., Potkin, S. G., & Enz, A. (2006). Targeting acetylcholinesterase and butyrylcholinesterase in dementia. The International Journal of Neuropsychopharmacology, 9(01), 101–124. doi:10.1017/S1461145705005833
   PubMedGoogle Scholar
• Li, J., Abel, R., Zhu, K., Cao, Y., Zhao, S., & Friesner, R. A. (2011). The VSGB 2.0 model: A next generation energy model for high resolution protein structure modeling. Proteins: Structure, Function, and Bioinformatics, 79(10), 2794–2812. doi:10.1002/prot.23106
   PubMed Web of Science ®Google Scholar
• Li, H., Robertson, A. D., Jensen, J. H. (2005). Very fast empirical prediction and rationalization of protein pKa values. Proteins, 61(4), 704–721.
   Google Scholar
• Lin, P. J., & Neumann, P. J. (2013). The economics of mild cognitive impairment. Alzheimer’s and Dementia, 9(1), 58–62.
   PubMed Web of Science ®Google Scholar
• LigPrep. (2015). Schrödinger, LLC, New York, NY.
   Google Scholar
• Ma, Z., & Tuckerman, M. (2010). Constant pressure ab initio molecular dynamics with discrete variable representation basis sets. Journal of Chemical Physics, 133(18), 184110. doi:10.1063/1.3499812
   PubMed Web of Science ®Google Scholar
• Maestro molecular modeling package. (2015). New York: Schrodinger.
   Google Scholar
• MarvinSketch 18.30.0. (2018). Budapest, Hungary: ChemAxon.
   Google Scholar
• Matthews, B. W. (1975). Comparison of the predicted and observed secondary structure of T4 phage lysozyme. Biochimica et Biophysica Acta (BBA), 405(2), 442–451. doi:10.1016/0005-2795(75)90109-9
   PubMed Web of Science ®Google Scholar
• McGaughey, G. B., Colussi, D., Graham, S. L., Lai, M. T., Munshi, S. K., Nantermet, P. G., … Holloway, M. K. (2007). Beta-secretase (BACE-1) inhibitors: Accounting for 10s loop flexibility using rigid active sites. Bioorganic & Medicinal Chemistry Letters, 17(4), 1117–1121. doi:10.1016/j.bmcl.2006.11.003
   PubMed Web of Science ®Google Scholar
• Meng, X. Y., Zhang, H. X., Mezei, M., & Cui, M. (2011). Molecular docking: A powerful approach for structure-based drug discovery. Current Computer-Aided Drug Design, 7(2), 146–157.
   PubMed Web of Science ®Google Scholar
• Motulsky, H. J. (2016). GraphPad statistics guide. GraphPad Software, San Diago.
   Google Scholar
• Munoz-Torrero, D. (2008). Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer’s disease. Current Medicinal Chemistry, 15(24), 2433–2455. doi:10.2174/092986708785909067
   PubMed Web of Science ®Google Scholar
• Ooms, F. (2000). Molecular modeling and computer aided drug design. Examples of their applications in medicinal chemistry. Current Medicinal Chemistry, 7(2), 141–158. doi:10.2174/0929867003375317
   PubMed Web of Science ®Google Scholar
• Ou-Yang, S. S., Lu, J. Y., Kong, X. Q., Liang, Z. J., Luo, C., & Jiang, H. (2012). Computational drug discovery. Acta Pharmacologica Sinica, 33(9), 1131–1140. doi:10.1038/aps.2012.109
   PubMed Web of Science ®Google Scholar
• Qiu, C., Kivipelto, M., & von Strauss, E. (2009). Epidemiology of Alzheimer’s disease: Occurrence, determinants, and strategies toward intervention. Dialogues in Clinical Neuroscience, 11(2), 111–128.
   PubMedGoogle Scholar
• Raha, K., & Merz, K. M. (2004). A quantum mechanics-based scoring function: Study of zinc ion-mediated ligand binding. Journal of the American Chemical Society, 126(4), 1020–1021. doi:10.1021/ja038496i
   PubMed Web of Science ®Google Scholar
• Roy, S., Kumar, A., Baig, M. H., Masařík, M., & Provazník, I. (2015). Virtual screening, ADMET profiling, molecular docking and dynamics approaches to search for potent selective natural molecules based inhibitors against metallothionein-III to study Alzheimer’s disease. Methods, 83, 105–110. doi:10.1016/j.ymeth.2015.04.021
   PubMed Web of Science ®Google Scholar
• Protein Preparation, Version 2.5. (2011). New York: Schrodinger, LLC.
   Google Scholar
• Salmas, R. E., Stein, M., Yurtsever, M., Seeman, P., Erol, I., Mestanoglu, M., & Durdagi, S. (2017). The signaling pathway of dopamine D2 receptor (D2R) activation using normal mode analysis (NMA) and the construction of pharmacophore models for D2R ligands. Journal of Biomolecular Structure and Dynamics, 35(9), 2040–2048. doi:10.1080/07391102.2016.1206487
   PubMed Web of Science ®Google Scholar
• Shelley, J. C., Cholleti, A., Frye, L. L., Greenwood, J. R., Timlin, M. R., & Uchimaya, M. (2007). Epik: A software program for pKa prediction and protonation state generation for drug-like molecules. Journal of Computer-Aided Molecular Design, 21(12), 681–691. doi:10.1007/s10822-007-9133-z
   PubMed Web of Science ®Google Scholar
• Subhani, S., Jayaraman, A., & Jamil, K. (2015). Homology modelling and molecular docking of MDR1 with chemotherapeutic agents in non-small cell lung cancer. Biomedicine & Pharmacotherapy, 71, 37–45. doi:10.1016/j.biopha.2015.02.009
   PubMed Web of Science ®Google Scholar
• Taber, D. F., & Tirunahari, P. K. (2011). Indole synthesis: A review and proposed classification. Tetrahedron, 67(38), 7195–7210.
   PubMed Web of Science ®Google Scholar
• Teipel, S., Heinsen, H., Amaro, E., Grinberg, L. T., Krause, B., Grothe, M., & Alzheimer’s Disease Neuroimaging Initiative (2014). Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer’s disease. Neurobiology of Aging, 35(3), 482–491. doi:10.1016/j.neurobiolaging.2013.09.029
   PubMed Web of Science ®Google Scholar
• Thompson, P. A., Wright, D. E., Counsell, C. E., & Zajicek, J. (2012). Statistical analysis, trial design and duration in Alzheimer’s disease clinical trials: A review. International Psychogeriatrics, 24(5), 689–697. doi:10.1017/S1041610211001116
   PubMed Web of Science ®Google Scholar
• Todeschini, R., Ballabio, D., & Grisoni, F. (2016). Beware of unreliable Q2! A comparative study of regression metrics for predictivity assessment of QSAR models. Journal of Chemical Information and Modeling, 56(10), 1905–1913. doi:10.1021/acs.jcim.6b00277
   PubMed Web of Science ®Google Scholar
• Turner, P. R., O’Connor, K., Tate, W. P., & Abraham, W. C. (2003). Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Progress in Neurobiology, 70(1), 1–32. doi:10.1016/S0301-0082(03)00089-3
   PubMed Web of Science ®Google Scholar
• Wolfe, M. S. (2001). Secretase targets for Alzheimer’s disease: Identification and therapeutic potential. Journal of Medicinal Chemistry, 44(13), 2039–2060. doi:10.1021/jm0004897
   PubMed Web of Science ®Google Scholar
• Xu, L., Sun, H., Li, Y., Wang, J., & Hou, T. (2013). Assessing the performance of MM/PBSA and MM/GBSA methods. 3. The impact of force fields and ligand charge models. The Journal of Physical Chemistry B, 117(28), 8408–8421. doi:10.1021/jp404160y
   PubMed Web of Science ®Google Scholar
• Zhang, X., Wong, S. E., & Lightstone, F. C. (2014). Toward fully automated high performance computing drug discovery: A massively parallel virtual screening pipeline for docking and molecular mechanics/generalized Born surface area rescoring to improve enrichment. Journal of Chemical Information and Modeling, 54(1), 324–337. doi:10.1021/ci4005145
   PubMed Web of Science ®Google Scholar